SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency

Schlotawa L, Ennemann E, Radhakrishnan K, Schmidt B, Chakrapani A, Christen H-J, Moser H, Steinmann B, Dierks T, Gaertner J (2011)
European Journal of Human Genetics 19(3): 253-261.

Zeitschriftenaufsatz | Veröffentlicht| Englisch
 
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Autor/in
Schlotawa, Lars; Ennemann, EvaUniBi; Radhakrishnan, Karthikeyan; Schmidt, Bernhard; Chakrapani, Anupam; Christen, Hans-Juergen; Moser, Hugo; Steinmann, Beat; Dierks, ThomasUniBi; Gaertner, Jutta
Abstract / Bemerkung
Multiple Sulfatase Deficiency (MSD) is caused by mutations in the sulfatase-modifying factor 1 gene encoding the formylglycine-generating enzyme (FGE). FGE post translationally activates all newly synthesized sulfatases by generating the catalytic residue formylglycine. Impaired FGE function leads to reduced sulfatase activities. Patients display combined clinical symptoms of single sulfatase deficiencies. For ten MSD patients, we determined the clinical phenotype, FGE expression, localization and stability, as well as residual FGE and sulfatase activities. A neonatal, very severe clinical phenotype resulted from a combination of two nonsense mutations leading to almost fully abrogated FGE activity, highly unstable FGE protein and nearly undetectable sulfatase activities. A late infantile mild phenotype resulted from FGE G263V leading to unstable protein but high residual FGE activity. Other missense mutations resulted in a late infantile severe phenotype because of unstable protein with low residual FGE activity. Patients with identical mutations displayed comparable clinical phenotypes. These data confirm the hypothesis that the phenotypic outcome in MSD depends on both residual FGE activity as well as protein stability. Predicting the clinical course in case of molecularly characterized mutations seems feasible, which will be helpful for genetic counseling and developing therapeutic strategies aiming at enhancement of FGE. European Journal of Human Genetics (2011) 19, 253-261; doi:10.1038/ejhg.2010.219; published online 12 January 2011
Stichworte
multiple sulfatase deficiency; sulfatase; formylglycine-generating enzyme; lysosomal storage disorders; SUMF1; genotype-phenotype correlation
Erscheinungsjahr
2011
Zeitschriftentitel
European Journal of Human Genetics
Band
19
Ausgabe
3
Seite(n)
253-261
ISSN
1018-4813
eISSN
1476-5438
Page URI
https://pub.uni-bielefeld.de/record/2003211

Zitieren

Schlotawa L, Ennemann E, Radhakrishnan K, et al. SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics. 2011;19(3):253-261.
Schlotawa, L., Ennemann, E., Radhakrishnan, K., Schmidt, B., Chakrapani, A., Christen, H. - J., Moser, H., et al. (2011). SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics, 19(3), 253-261. doi:10.1038/ejhg.2010.219
Schlotawa, L., Ennemann, E., Radhakrishnan, K., Schmidt, B., Chakrapani, A., Christen, H. - J., Moser, H., Steinmann, B., Dierks, T., and Gaertner, J. (2011). SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics 19, 253-261.
Schlotawa, L., et al., 2011. SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics, 19(3), p 253-261.
L. Schlotawa, et al., “SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency”, European Journal of Human Genetics, vol. 19, 2011, pp. 253-261.
Schlotawa, L., Ennemann, E., Radhakrishnan, K., Schmidt, B., Chakrapani, A., Christen, H.-J., Moser, H., Steinmann, B., Dierks, T., Gaertner, J.: SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics. 19, 253-261 (2011).
Schlotawa, Lars, Ennemann, Eva, Radhakrishnan, Karthikeyan, Schmidt, Bernhard, Chakrapani, Anupam, Christen, Hans-Juergen, Moser, Hugo, Steinmann, Beat, Dierks, Thomas, and Gaertner, Jutta. “SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency”. European Journal of Human Genetics 19.3 (2011): 253-261.

19 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Expression, activity and localization of lysosomal sulfatases in Chronic Obstructive Pulmonary Disease.
Weidner J, Jogdand P, Jarenbäck L, Åberg I, Helihel D, Ankerst J, Westergren-Thorsson G, Bjermer L, Erjefält JS, Tufvesson E., Sci Rep 9(1), 2019
PMID: 30760748
Sulfation pathways from red to green.
Günal S, Hardman R, Kopriva S, Mueller JW., J Biol Chem 294(33), 2019
PMID: 31270211
The report of two cases with multiple sulfatase deficiency resulting from a rare similar gene mutation.
Ashrafzadeh F, Zabolinejad N, Ghayoor Karimiani E, Beiraghi Toosi M, Doniadideh N, Torabi S, Razmyar M, Sheikh Andalibi MS., Int J Dermatol 57(10), 2018
PMID: 29479672
Multiple Sulfatase Deficiency: A Case Series With a Novel Mutation.
Hijazi L, Kashgari A, Alfadhel M., J Child Neurol 33(13), 2018
PMID: 30124108
Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
Weidner J, Jarenbäck L, de Jong K, Vonk JM, van den Berge M, Brandsma CA, Boezen HM, Sin D, Bossé Y, Nickle D, Ankerst J, Bjermer L, Postma DS, Faiz A, Tufvesson E., Respir Res 18(1), 2017
PMID: 28464818
Clinical and molecular cytogenetic analyses of four patients with imbalanced translocations.
Liu HY, Huang J, Li T, Wu D, Wang HD, Wang Y, Wang T, Guo LJ, Guo QN, Huang FF, Wang RL, Wang YT., Mol Cytogenet 9(), 2016
PMID: 27099631
Protecting the mitochondrial powerhouse.
Scheibye-Knudsen M, Fang EF, Croteau DL, Wilson DM, Bohr VA., Trends Cell Biol 25(3), 2015
PMID: 25499735
Natural disease history and characterisation of SUMF1 molecular defects in ten unrelated patients with multiple sulfatase deficiency.
Sabourdy F, Mourey L, Le Trionnaire E, Bednarek N, Caillaud C, Chaix Y, Delrue MA, Dusser A, Froissart R, Garnotel R, Guffon N, Megarbane A, Ogier de Baulny H, Pédespan JM, Pichard S, Valayannopoulos V, Verloes A, Levade T., Orphanet J Rare Dis 10(), 2015
PMID: 25885655
Microduplications of 3p26.3p26.2 containing CRBN gene in patients with intellectual disability and behavior abnormalities.
Papuc SM, Hackmann K, Andrieux J, Vincent-Delorme C, Budişteanu M, Arghir A, Schrock E, Ţuţulan-Cuniţă AC, Di Donato N., Eur J Med Genet 58(5), 2015
PMID: 25858704
The Regulation of Steroid Action by Sulfation and Desulfation.
Mueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA., Endocr Rev 36(5), 2015
PMID: 26213785
A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome.
Chung YK, Sohn YB, Sohn JM, Lee J, Chang MS, Kwun Y, Kim CH, Lee JY, Yook YJ, Ko AR, Jin DK., Glycoconj J 31(4), 2014
PMID: 24781369
Molecular evaluation of a novel missense mutation & an insertional truncating mutation in SUMF1 gene.
Kotecha UH, Movva S, Sharma D, Verma J, Puri RD, Verma IC., Indian J Med Res 140(1), 2014
PMID: 25222778
Case of multiple sulfatase deficiency and ocular albinism: a diagnostic odyssey.
Prasad C, Rupar CA, Campbell C, Napier M, Ramsay D, Tay KY, Sharan S, Prasad AN., Can J Neurol Sci 41(5), 2014
PMID: 25373814
Multiple sulfatase deficiency with neonatal manifestation.
Garavelli L, Santoro L, Iori A, Gargano G, Braibanti S, Pedori S, Melli N, Frattini D, Zampini L, Galeazzi T, Padella L, Pepe S, Wischmeijer A, Rosato S, Ivanovski I, Iughetti L, Gelmini C, Bernasconi S, Superti-Furga A, Ballabio A, Gabrielli O., Ital J Pediatr 40(), 2014
PMID: 25516103
Rapid degradation of an active formylglycine generating enzyme variant leads to a late infantile severe form of multiple sulfatase deficiency.
Schlotawa L, Radhakrishnan K, Baumgartner M, Schmid R, Schmidt B, Dierks T, Gärtner J., Eur J Hum Genet 21(9), 2013
PMID: 23321616
Recognition and diagnosis of neuro-ichthyotic syndromes.
Rizzo WB, Jenkens SM, Boucher P., Semin Neurol 32(1), 2012
PMID: 22422210

45 References

Daten bereitgestellt von Europe PubMed Central.

Multiple sulfatase deficiency and the nature of the sulfatase family
Hopwood J, Ballabio A., 2001

Nyhan WL, Ozand PT., 1998

Van M, Valk J., 2005
Pathochemistry, pathogenesis and enzyme replacement in multiple-sulfatase deficiency.
Eto Y, Gomibuchi I, Umezawa F, Tsuda T., Enzyme 38(1-4), 1987
PMID: 2894304
Unusual early manifestation of multiple sulfatase deficiency.
Perlmutter-Cremer N, Libert J, Vamos E, Spehl M, Liebaers I., Ann Radiol (Paris) 24(1), 1981
PMID: 6781400
Multiple sulphatase deficiency with early onset.
Vamos E, Liebaers I, Bousard N, Libert J, Perlmutter N., J. Inherit. Metab. Dis. 4(2), 1981
PMID: 6115093
Multiple sulphatase deficiency presenting at birth.
Burch M, Fensom AH, Jackson M, Pitts-Tucker T, Congdon PJ., Clin. Genet. 30(5), 1986
PMID: 3100114
Neonatal manifestation of multiple sulfatase deficiency.
Busche A, Hennermann JB, Burger F, Proquitte H, Dierks T, von Arnim-Baas A, Horn D., Eur. J. Pediatr. 168(8), 2008
PMID: 19066960
Clinical and mutational characterization of three patients with multiple sulfatase deficiency: report of a new splicing mutation.
Diaz-Font A, Santamaria R, Cozar M, Blanco M, Chamoles N, Coll MJ, Chabas A, Vilageliu L, Grinberg D., Mol. Genet. Metab. 86(1-2), 2005
PMID: 16125993
Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins.
Dierks T, Schlotawa L, Frese MA, Radhakrishnan K, von Figura K, Schmidt B., Biochim. Biophys. Acta 1793(4), 2008
PMID: 19124046
Pitfalls in the diagnosis of multiple sulfatase deficiency.
Mancini GM, van Diggelen OP, Huijmans JG, Stroink H, de Coo RF., Neuropediatrics 32(1), 2001
PMID: 11315200
Mild ichthyosis in a 4-year-old boy with multiple sulphatase deficiency
Loffeld A, Gray RG, Green SH, Roper HP, Moss C., 2002
Saudi variant of multiple sulfatase deficiency.
al Aqeel A, Ozand PT, Brismar J, Gascon GG, Brismar G, Nester M, Sakati N., J. Child Neurol. 7 Suppl(), 1992
PMID: 1588009
Unusual clinical presentation in two cases of multiple sulfatase deficiency.
Blanco-Aguirre ME, Kofman-Alfaro SH, Rivera-Vega MR, Medina C, Valdes-Flores M, Rizzo WB, Cuevas-Covarrubias SA., Pediatr Dermatol 18(5), 2001
PMID: 11737681
Sulfatases and human disease.
Diez-Roux G, Ballabio A., Annu Rev Genomics Hum Genet 6(), 2005
PMID: 16124866
Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum
Dierks T, Schmidt B, von K., 1997
A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency.
Schmidt B, Selmer T, Ingendoh A, von Figura K., Cell 82(2), 1995
PMID: 7628016
Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases.
Dierks T, Lecca MR, Schlotterhose P, Schmidt B, von Figura K., EMBO J. 18(8), 1999
PMID: 10205163
Molecular basis for multiple sulfatase deficiency and mechanism for formylglycine generation of the human formylglycine-generating enzyme.
Dierks T, Dickmanns A, Preusser-Kunze A, Schmidt B, Mariappan M, von Figura K, Ficner R, Rudolph MG., Cell 121(4), 2005
PMID: 15907468
ERp44 mediates a thiol-independent retention of formylglycine-generating enzyme in the endoplasmic reticulum.
Mariappan M, Radhakrishnan K, Dierks T, Schmidt B, von Figura K., J. Biol. Chem. 283(10), 2008
PMID: 18178549
The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases.
Cosma MP, Pepe S, Annunziata I, Newbold RF, Grompe M, Parenti G, Ballabio A., Cell 113(4), 2003
PMID: 12757706
Multiple sulfatase deficiency is caused by mutations in the gene encoding the human C(alpha)-formylglycine generating enzyme.
Dierks T, Schmidt B, Borissenko LV, Peng J, Preusser A, Mariappan M, von Figura K., Cell 113(4), 2003
PMID: 12757705
Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency
Settembre C, Annunziata I, Spampanato C., 2007
Multiple sulfatase deficiency is due to hypomorphic mutations of the SUMF1 gene.
Annunziata I, Bouche V, Lombardi A, Settembre C, Ballabio A., Hum. Mutat. 28(9), 2007
PMID: 17657823
Molecular and functional analysis of SUMF1 mutations in multiple sulfatase deficiency.
Cosma MP, Pepe S, Parenti G, Settembre C, Annunziata I, Wade-Martins R, Di Domenico C, Di Natale P, Mankad A, Cox B, Uziel G, Mancini GM, Zammarchi E, Donati MA, Kleijer WJ, Filocamo M, Carrozzo R, Carella M, Ballabio A., Hum. Mutat. 23(6), 2004
PMID: 15146462
Multiple sulfatase deficiency: clinical report and description of two novel mutations in a Brazilian patient.
Artigalas OA, da Silva LR, Burin M, Pastores GM, Zeng B, Macedo N, Schwartz IV., Metab Brain Dis 24(3), 2009
PMID: 19697114
A newly recognized cause of low urinary estriol in pregnancy: multiple sulfatase deficiency of the fetus.
Steinmann B, Mieth D, Gitzelmann R., Gynecol. Obstet. Invest. 12(2), 1981
PMID: 7262633
Molecular characterization of the human Calpha-formylglycine-generating enzyme.
Preusser-Kunze A, Mariappan M, Schmidt B, Gande SL, Mutenda K, Wenzel D, von Figura K, Dierks T., J. Biol. Chem. 280(15), 2005
PMID: 15657036
Multiple sulfatase deficiency: catalytically inactive sulfatases are expressed from retrovirally introduced sulfatase cDNAs
Rommerskirch W, von K., 1992
A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).
Voznyi YV, Keulemans JL, van Diggelen OP., J. Inherit. Metab. Dis. 24(6), 2001
PMID: 11768586
The non-catalytic N-terminal extension of formylglycine-generating enzyme is required for its biological activity and retention in the endoplasmic reticulum.
Mariappan M, Gande SL, Radhakrishnan K, Schmidt B, Dierks T, von Figura K., J. Biol. Chem. 283(17), 2008
PMID: 18305113
A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme
Roeser D, Preusser-Kunze A, Schmidt B., 2006
Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum.
Fey J, Balleininger M, Borissenko LV, Schmidt B, von Figura K, Dierks T., J. Biol. Chem. 276(50), 2001
PMID: 11600503
One step at a time: endoplasmic reticulum-associated degradation.
Vembar SS, Brodsky JL., Nat. Rev. Mol. Cell Biol. 9(12), 2008
PMID: 19002207
Multistep, sequential control of the trafficking and function of the multiple sulfatase deficiency gene product, SUMF1 by PDI, ERGIC-53 and ERp44.
Fraldi A, Zito E, Annunziata F, Lombardi A, Cozzolino M, Monti M, Spampanato C, Ballabio A, Pucci P, Sitia R, Cosma MP., Hum. Mol. Genet. 17(17), 2008
PMID: 18508857
Sulfatase modifying factor 1 trafficking through the cells: from endoplasmic reticulum to the endoplasmic reticulum.
Zito E, Buono M, Pepe S, Settembre C, Annunziata I, Surace EM, Dierks T, Monti M, Cozzolino M, Pucci P, Ballabio A, Cosma MP., EMBO J. 26(10), 2007
PMID: 17446859
Synthesis and stability of steroid sulfatase in fibroblasts from multiple sulfatase deficiency.
Conary JT, Hasilik A, von Figura K., Biol. Chem. Hoppe-Seyler 369(4), 1988
PMID: 3165268
Multiple sulfatase deficiency: degradation of arylsulfatase A and B after endocytosis in fibroblasts.
Steckel F, Hasilik A, von Figura K., Eur. J. Biochem. 151(1), 1985
PMID: 2863139
Synthesis and stability of arylsulfatase A and B in fibroblasts from multiple sulfatase deficiency.
Steckel F, Hasilik A, von Figura K., Eur. J. Biochem. 151(1), 1985
PMID: 2863138
Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
Sawkar AR, Adamski-Werner SL, Cheng WC, Wong CH, Beutler E, Zimmer KP, Kelly JW., Chem. Biol. 12(11), 2005
PMID: 16298303
Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.
Ulloa-Aguirre A, Janovick JA, Brothers SP, Conn PM., Traffic 5(11), 2004
PMID: 15479448

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 21224894
PubMed | Europe PMC

Suchen in

Google Scholar